A clinical trial testing an experimental vaccine for the Epstein-Barr virus (EBV) in people with MS is now recruiting ...

Tyruko, the first biosimilar of Tysabri, is now available in the U.S., providing a lower-cost treatment option for adults ...

Guest writer Shara Sand says that her severe mood changes went unidentified until a psychiatrist diagnosed her with bipolar ...

Vision changes with SPMS can involve slow visual processing and motion sensitivity, but it’s possible to manage them.

Shara Sand is a practicing psychologist and retired associate professor. She specializes in gender, sexuality, and disability issues and works with creative and performing artists. Shara identifies as ...

MS and MOGAD share similar symptoms but are two biologically distinct conditions, with different immune signatures, a study ...

Mesenchymal stem cell therapy shows promise for treating MS, but more research is needed on long-term safety and efficacy, a ...

Understanding changes, seeking support, and staying connected can help caregivers adapt to the challenges of secondary progressive MS.

Maybe healing after an MS relapse isn't in striving to feel better, but is found in savoring where you are now, writes ...

As Thanksgiving approaches, columnist Leigh Anne Nelson is focused on what gratitude really means and appreciating the small ...

Zydus won final FDA approval to market a generic version of Vumerity for adults with relapsing forms of MS and active SPMS.